Essilor Pro-Eyecare A.I CyberSecurity Scoring
25/01/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Essilor Pro-Eyecare in 2026.
No incidents recorded for Essilor Pro-Eyecare in 2026.
No incidents recorded for Essilor Pro-Eyecare in 2026.
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.
We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can-do attitude, we work together to win.. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited. Please note: not all products referred to may be approved for use or available in all markets.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
As a leading medical technology company, B. Braun protects and improves the health of people around the world. For more than 185 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits. More than 64,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops integrated solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2024, the B. Braun Group generated sales of € 9.1 billion. Imprint: https://www.bbraun.com/en/imprint.html Privacy Policy: https://www.bbraun.com/en/privacy-policy.html
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
Latest updates, reports, and threat intel affecting the global network.
Klever-Go is the Go implementation of the Klever blockchain protocol. Versions from 1.7.14 through 1.7.17 are vulnerable to a remotely triggerable denial of service. Both REST APIs are started with the Gin Engine.Run convenience method, which serves requests through Go's default HTTP server with no ReadHeaderTimeout, ReadTimeout, or MaxHeaderBytes configured. As a result, incoming connections that never complete their request headers are held open indefinitely. When a REST listener is reachable beyond localhost through the documented all-interface bind or a Docker port-publish deployment, a single unauthenticated client can open many slow-header connections and hold them open until server file descriptors are exhausted, preventing the API from accepting new connections. This renders the REST API unavailable to legitimate clients. This issue is fixed in version 1.7.18.
Klever-Go is the Go implementation of the Klever blockchain protocol. In versions 1.7.14 through 1.7.17, the direct-message ingress handler spawns a new goroutine for every incoming direct message before the processor-level antiflood layer makes any admission decision, with no semaphore, throttler, or bound on the number of concurrent in-flight spawns. Because the antiflood check runs inside the spawned goroutine rather than before it, a single connected peer can open a direct-send stream and send a stream of well-formed messages to force unbounded goroutine creation, where each goroutine allocates its own stack and holds a message reference until processing completes, adding scheduler and garbage-collection pressure faster than the runtime can drain it. This lets one peer degrade the node's availability and its ability to process legitimate traffic, resulting in a remotely triggerable denial of service. The issue is fixed in 1.7.18.
Klever-Go is the Go implementation of the Klever blockchain protocol. Versions 1.7.14 through 1.7.17 are vulnerable to a nil-pointer panic triggered by a protobuf Transaction whose embedded RawData sub-message is omitted. This omission causes RawData to decode to nil. Every transaction gossiped on the Klever-Go P2P network is decoded and validated synchronously inside the libp2p pubsub topic-validator callback, where txVersionChecker.CheckTxVersion dereferences tx.RawData.Version with no nil check. Because the libp2p pubsub callback, the underlying go-libp2p-pubsub validation worker, and Klever's own network/p2p layer install no recover(), the panic propagates and crashes the entire node process. The attacker payload is a 3-byte protobuf message; no validator key, stake, funds, or on-chain account is required, and delivery aimed at enough of the BLS validator set can halt block production, resulting in a chain halt. This issue has been fixed in version 1.7.18.
Klever-Go is the Go implementation of the Klever blockchain protocol. In versions prior to 1.7.18, the account-data trie syncers are vulnerable to a resource-exhaustion flaw that leaks bounded throttler slots on error paths. In syncDataTrie() (in both userAccountsSyncer.go and kappAccountsSyncer.go), StartProcessing() reserves a slot from the NumGoRoutinesThrottler, but the corresponding EndProcessing() is only called on the success path and on the duplicate-root early return. As a result, any error from trie.NewTrie(), trie.NewTrieSyncer(), or trieSyncer.StartSyncing() (including the network-dependent timeout path) permanently consumes one slot for the lifetime of the throttler. An attacker who can repeatedly cause trie-node sync failures or timeouts during bootstrap can exhaust the bounded throttler, after which further account-data trie syncs stop making progress and SyncAccounts() returns a timeout. Because epoch bootstrap in syncUserAccountsState() and syncKappAccountsState() aborts on any such error, this causes bootstrap to fail, a core availability issue affecting fresh, restarting, or resyncing nodes and validators. This issue is fixed in version 1.7.18.
Ruby LSP is an implementation of the language server protocol for Ruby. Several workspace-level settings in the Ruby LSP VS Code extension prior to version 0.10.4 could override the path to the Ruby executable, the version manager executables, or the Bundler `Gemfile` used at startup. A malicious repository containing a `.vscode/settings.json` could set these values to attacker-controlled targets. Opening and trusting the repository would then execute code with the privileges of the developer. The Ruby LSP gem and clients of the language server in other editors are not affected. Version 0.10.4 of the Ruby LSP VS Code extension fixes the issue.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.